Motealleh A, Kehr NS. Injectable oxygen-generating nanocomposite hydrogels with extended oxygen supply for enhanced cell proliferation underneath hypoxic and normoxic circumstances. J Mater Chem B. 2020;8(19):4195–201.
Ashammakhi N, et al. Advances in managed oxygen producing biomaterials for tissue engineering and regenerative remedy. Biomacromol. 2020;21(1):56–72.
Biro GP. Oxygen and ATP: the Vitality Economic system of the Cell. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer Worldwide Publishing; 2022. p. 21–32.
Werner M, et al. Femoral blood fuel evaluation, one other device to evaluate hemorrhage severity following trauma: an exploratory potential research. Scand J Trauma Resusc Emerg Med. 2023;31(1):31.
Dyer WB, et al. Restoration of organ-specific tissue oxygen supply at restrictive transfusion thresholds after fluid remedy in ovine haemorrhagic shock. Intensive Care Med Exp. 2022;10(1):12.
Chen WR, Chou CC, Wang CC. Phthalides function potent modulators to spice up fetal hemoglobin induction remedy for β-hemoglobinopathies. Blood Adv. 2019;3(9):1493–8.
Hönemann JN, et al. Hypoxia and cardiac perform in sufferers with prior myocardial infarction. Circ Res. 2023;132(9):1165–7.
Kabra R, et al. Hidden thriller behind unilateral cerebellar infarction in hanging: a case report. Cureus. 2022;14(11):e31115.
Köhler D, et al. Hypoxic, anemic and cardiac hypoxemia: When does tissue hypoxia start? Dtsch Med Wochenschr. 2023;148(8):475–82.
Godoy DA, et al. Avoiding mind hypoxia in extreme traumatic mind harm in settings with restricted assets—a pathophysiological information. J Crit Care. 2023;75:154260.
Haddon A, et al. Cardiorespiratory responses to voluntary hyperventilation throughout normobaric hypoxia. Aerosp Med Hum Carry out. 2023;94(2):59–65.
Wang L, et al. Shen Shuai II recipe inhibits hypoxia-induced glycolysis by preserving mitochondrial dynamics to attenuate kidney fibrosis. J Ethnopharmacol. 2023;308:116271.
Biro GP. Erythrocyte transfusion: transient historical past and present follow. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer Worldwide Publishing; 2022. p. 3–19.
Lee P, Chandel NS, Simon MC. Mobile adaptation to hypoxia by way of hypoxia inducible elements and past. Nat Rev Mol Cell Biol. 2020;21(5):268–83.
Chen Z, et al. Hypoxic microenvironment in most cancers: molecular mechanisms and therapeutic interventions. Sign Transduct Goal Ther. 2023;8(1):70.
Li B, et al. PEG-conjugated bovine haemoglobin enhances effectivity of chemotherapeutic agent doxorubicin with assuaging DOX-induced splenocardiac toxicity within the breast most cancers. Artif Cells Nanomed Biotechnol. 2023;51(1):120–30.
Luo Z, et al. Hypoxia signaling in human well being and ailments: implications and prospects for therapeutics. Sign Transduct Goal Ther. 2022;7(1):218.
Cherian VT. Physiological capabilities of blood. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer Worldwide Publishing; 2022. p. 33–43.
Cohn EJ. Blood: a short survey of its chemical parts and of their pure capabilities and scientific makes use of. Blood. 2015;126(24):2531.
Mohanto N, Park YJ, Jee JP. Present views of synthetic oxygen carriers as crimson blood cell substitutes: a assessment of previous to cutting-edge applied sciences utilizing in vitro and in vivo assessments. J Pharm Investig. 2023;53(1):153–90.
Ahmed MH, Ghatge MS, Safo MK. Hemoglobin: construction, perform and allostery. In: Hoeger U, Harris JR, editors. Vertebrate and invertebrate respiratory proteins, lipoproteins and different physique fluid proteins. Cham: Springer Worldwide Publishing; 2020. p. 345–82.
Shu P, et al. Cefmetazole sodium as an allosteric effector that regulates the oxygen provide effectivity of grownup hemoglobin. J Biomol Struct Dyn. 2023. https://doi.org/10.1080/07391102.2023.2245043.
Yu S. Hemoglobin: physiology and hemoglobinopathy. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer Worldwide Publishing; 2022. p. 45–51.
Liu WL, et al. Aggressive man-made crimson blood cells for hypoxia-resistant photodynamic remedy. Adv Mater. 2018;30(35):e1802006.
Zujalovic B, Hafner S. Harm management resuscitation: identification and remedy of life-threatening hemorrhage. Anesth Analg. 2020;130(5):e141–2.
Carreau A, et al. Why is the partial oxygen stress of human tissues a vital parameter? Small molecules and hypoxia. J Cell Mol Med. 2011;15(6):1239–53.
Haque N, et al. Hypoxic tradition circumstances as an answer for mesenchymal stem cell based mostly regenerative remedy. Sci World J. 2013;2013:632972.
Khan F, Singh Okay, Friedman MT. Synthetic blood: the historical past and present views of blood substitutes. Discoveries (Craiova). 2020;8(1):e104.
Bialas C, Moser C, Sims CA. Synthetic oxygen carriers and crimson blood cell substitutes: A historic overview and up to date developments towards navy and scientific relevance. J Trauma Acute Care Surg. 2019;87(1S):S48-s58.
Stanworth SJ, et al. Results of the COVID-19 pandemic on provide and use of blood for transfusion. Lancet Haematol. 2020;7(10):e756–64.
Coll-Satue C, et al. Stepping stones to the way forward for haemoglobin-based blood merchandise: scientific, preclinical and progressive examples. Biomater Sci. 2021;9(4):1135–52.
Dumont LJ, et al. In a single day, room temperature maintain of entire blood adopted by 42-day storage of crimson blood cells in additive solution-7. Transfusion. 2015;55(3):485–90.
Model A. Immunological issues of blood transfusions. Presse Med. 2016;45(7–8 Pt 2):e313–24.
Xia S, et al. Addition of sodium pyruvate to saved crimson blood cells attenuates liver harm in a murine transfusion mannequin. Mediators Inflamm. 2016;2016:3549207.
Charbe NB, et al. A brand new period in oxygen therapeutics? From perfluorocarbon techniques to haemoglobin-based oxygen carriers. Blood Rev. 2022;54:100927.
Rangayasami A, et al. Affect of nanotechnology to fight in opposition to COVID-19 for world well being emergency: a assessment. Sensors Worldwide. 2021;2:100079.
Berg L, et al. Obstetric outcomes in Jehovah’s Witnesses: case collection over 9 years in a London educating hospital. Arch Gynecol Obstet. 2023. https://doi.org/10.1007/s00404-023-06940-x.
Naicker YD, Ahmed N, Davids R. Harm management surgical procedure of the essential Jehovah’s Witness affected person—a story assessment. S Afr J Surg. 2023;61(1):39–44.
Liu H, et al. Classifications of blood substitutes. In: Liu H, Kaye AD, Jahr JS, editors., et al., Blood substitutes and oxygen biotherapeutics. Cham: Springer Worldwide Publishing; 2022. p. 119–29.
Jahr JS, et al. Blood substitutes and oxygen therapeutics: a assessment. Anesth Analg. 2021;132(1):119–29.
Wu L, et al. Perfluorocarbons-based (19)F magnetic resonance imaging in biomedicine. Int J Nanomed. 2020;15:7377–95.
Castro CI, Briceno JC. Perfluorocarbon-based oxygen carriers: assessment of merchandise and trials. Artif Organs. 2010;34(8):622–34.
Park KM, Gerecht S. Hypoxia-inducible hydrogels. Nat Commun. 2014;5:4075.
Spahn DR, Kocian R. Synthetic O2 carriers: standing in 2005. Curr Pharm Des. 2005;11(31):4099–114.
Chen L, Yang Z, Liu H. Hemoglobin-based oxygen carriers: the place are we now in 2023? Med (Kaunas). 2023. https://doi.org/10.3390/medicina59020396.
Mer M, et al. Hemoglobin glutamer-250 (bovine) in South Africa: consensus utilization tips from clinician consultants who’ve handled sufferers. Transfusion. 2016;56(10):2631–6.
Cao M, et al. New functions of HBOC-201: a 25-year assessment of the literature. Entrance Med (Lausanne). 2021;8:794561.
Romito BT, et al. The impact of SANGUINATE(®) (PEGylated carboxyhemoglobin bovine) on cardiopulmonary bypass performance utilizing a bovine entire blood mannequin of normovolemic hemodilution. Perfusion. 2020;35(1):19–25.
Marrazzo F, et al. Inhaled nitric oxide prevents systemic and pulmonary vasoconstriction because of hemoglobin-based oxygen provider infusion: A case report. J Crit Care. 2019;51:213–6.
Wang Y, et al. Structural, purposeful and physiochemical properties of dextran-bovine hemoglobin conjugate as a hemoglobin-based oxygen provider. Course of Biochem. 2017;60:67–73.
Huo S, et al. Ferrous hemoglobin and hemoglobin-based oxygen carriers appearing as a peroxidase can inhibit oxidative injury to endothelial cells attributable to hydrogen peroxide. Artif Organs. 2021;45(10):1229–39.
Li T, Jing X, Huang Y. Polymer/hemoglobin assemblies: biodegradable oxygen carriers for synthetic crimson blood cells. Macromol Biosci. 2011;11(7):865–75.
Moradi S, Jahanian-Najafabadi A, Roudkenar MH. Synthetic blood substitutes: first steps on the lengthy path to scientific utility. Clin Med Insights Blood Disord. 2016;9:33–41.
Sen Gupta A. Hemoglobin-based oxygen carriers: present state-of-the-art and novel molecules. Shock. 2019;52(1S):70–83.
Wang Y, et al. A PEGylated bovine hemoglobin as a potent hemoglobin-based oxygen provider. Biotechnol Prog. 2017;33(1):252–60.
Bian Y, Chang TM. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat mannequin with 90 minutes of sustained extreme hemorrhagic shock with lack of 2/3 blood quantity. Artif Cells Nanomed Biotechnol. 2015;43(1):1–9.
Chang TM. Blood alternative with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(4):418–30.
Bian Y, Chang TMS. Nanobiotechnological foundation of an oxygen provider with enhanced carbonic anhydrase for CO(2) transport and enhanced catalase and superoxide dismutase for antioxidant perform. Entrance Bioeng Biotechnol. 2023;11:1188399.
Mitchell MJ, et al. Engineering precision nanoparticles for drug supply. Nat Rev Drug Discov. 2021;20(2):101–24.
Bäumler H, Xiong Y, Georgieva R. Nanotechnology-based oxygen and drug carriers. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer Worldwide Publishing; 2022. p. 169–73.
Modery-Pawlowski CL, et al. Artificial approaches to RBC mimicry and oxygen provider techniques. Biomacromol. 2013;14(4):939–48.
Liu X, et al. Low-fouling electrosprayed hemoglobin nanoparticles with antioxidant safety as promising oxygen carriers. Macromol Biosci. 2020;20(2):e1900293.
Nadimifar M, et al. Synthesis of bioactive hemoglobin-based oxygen provider nanoparticles through metal-phenolic complexation. Biomater Adv. 2024;156:213698.
Chang TMS. A quick historical past of the event of nanobiotechnology-based blood substitutes. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer Worldwide Publishing; 2022. p. 99–115.
Matsuhira T, Sakai H. Synthetic oxygen carriers, from nanometer- to micrometer-sized particles, product of hemoglobin composites substituting for crimson blood cells. Particuology. 2022;64:43–55.
Jia Y, Duan L, Li J. Hemoglobin-based nanoarchitectonic assemblies as oxygen carriers. Adv Mater. 2016;28(6):1312–8.
Tao Z, Ghoroghchian PP. Microparticle, nanoparticle, and stem cell-based oxygen carriers as superior blood substitutes. Developments Biotechnol. 2014;32(9):466–73.
Jansman MMT, Hosta-Rigau L. Latest and distinguished examples of nano- and microarchitectures as hemoglobin-based oxygen carriers. Adv Colloid Interface Sci. 2018;260:65–84.
Kaneda S, et al. Liposome-encapsulated hemoglobin, TRM-645: present standing of the event and necessary points for scientific utility. Artif Organs. 2009;33(2):146–52.
Lu M, et al. Preparation, characterization and in vivo investigation of blood-compatible hemoglobin-loaded nanoparticles as oxygen carriers. Colloid Surf B Biointerfaces. 2016;139:171–9.
Xu X, et al. A photosensitizer loaded hemoglobin-polymer conjugate as a nanocarrier for enhanced photodynamic remedy. J Mater Chem B. 2018;6(12):1825–33.
Yuan M, et al. A strong oxygen-carrying hemoglobin-based pure sonosensitizer for sonodynamic most cancers remedy. Nano Lett. 2021;21(14):6042–50.
Pozy E, Savla C, Palmer AF. Photocatalytic synthesis of a polydopamine-coated acellular mega-hemoglobin as a possible oxygen therapeutic with antioxidant properties. Biomacromol. 2023;24(5):2022–9.
Peng S, et al. Metallic-organic framework encapsulating hemoglobin as a high-stable and long-circulating oxygen carriers to deal with hemorrhagic shock. ACS Appl Mater Interfaces. 2019;11(39):35604–12.
Cun X, et al. Hemoglobin-stabilized gold nanoclusters displaying oxygen transport capability, self-antioxidation, auto-fluorescence properties and long-term storage potential. RSC Adv. 2023;13(23):15540–53.
Tang W, et al. Purple blood cell-facilitated photodynamic remedy for most cancers remedy. Adv Funct Mater. 2016;26(11):1757–68.
Wang Q, et al. Bioinspired polydopamine-coated hemoglobin as potential oxygen provider with antioxidant properties. Biomacromol. 2017;18(4):1333–41.
Hu J, et al. Polydopamine-based floor modification of hemoglobin particles for stability enhancement of oxygen carriers. J Colloid Interface Sci. 2020;571:326–36.
Li Y, et al. Synthetic nonenzymatic antioxidant mxene nanosheet-anchored injectable hydrogel as a light photothermal-controlled oxygen launch platform for diabetic wound therapeutic. ACS Nano. 2022;16(5):7486–502.
Pan D, et al. Erythromer (EM), a nanoscale bio-synthetic synthetic crimson cell: proof of idea and in vivo efficacy outcomes. Blood. 2016;128(22):1027–1027.
Liu P, et al. Bioinspired nanoerythrocytes for metabolic microenvironment reworking and long-term prognosis selling of acute ischemic stroke. Nano As we speak. 2023;49:101806.
Bu H, et al. Synthesis of a hemoglobin-conjugated triblock copolymer for oxygen carrying and particular recognition of most cancers cells. RSC Adv. 2017;7(76):48166–75.
Tian H, et al. Most cancers cell membrane-biomimetic oxygen nanocarrier for breaking hypoxia-induced chemoresistance. Adv Func Mater. 2017;27(38):1703197.
Wang Y, et al. Engineering endogenous tumor-associated macrophage-targeted biomimetic nano-RBC to reprogram tumor immunosuppressive microenvironment for enhanced chemo-immunotherapy. Adv Mater. 2021;33(39):e2103497.
Xia D, et al. Au-hemoglobin loaded platelet assuaging tumor hypoxia and enhancing the radiotherapy impact with low-dose X-ray. ACS Nano. 2020;14(11):15654–68.
Zhang X, et al. Black phosphorus-loaded separable microneedles as responsive oxygen supply carriers for wound therapeutic. ACS Nano. 2020;14(5):5901–8.
Munoz C, et al. Resuscitation after hemorrhagic shock within the microcirculation: concentrating on optimum oxygen supply within the design of synthetic blood substitutes. Entrance Med (Lausanne). 2020;7:585638.
Chen G, et al. Results of artificial colloids on oxidative stress and inflammatory response in hemorrhagic shock: comparability of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin. Crit Care. 2013;17(4):R141.
Bragin DE, et al. Addition of drag-reducing polymers to colloid resuscitation fluid enhances cerebral microcirculation and tissue oxygenation after traumatic mind harm difficult by hemorrhagic shock. Adv Exp Med Biol. 2021;1269:283–8.
Dyer WB, et al. An ovine mannequin of hemorrhagic shock and resuscitation, to evaluate restoration of tissue oxygen supply and oxygen debt, and inform affected person blood administration. Shock. 2021;56(6):1080–91.
Hallisey SD, Greenwood JC. Past imply arterial stress and lactate: perfusion finish factors for managing the shocked affected person. Emerg Med Clin North Am. 2019;37(3):395–408.
Yamamoto M, et al. Fluid resuscitation of hemorrhagic shock with hemoglobin vesicles in Beagle canines: pilot research. Artif Cells Blood Substit Immobil Biotechnol. 2012;40(1–2):179–95.
Yuki Y, et al. Efficacy of resuscitative infusion with hemoglobin vesicles in rabbits with large obstetric hemorrhage. Am J Obstet Gynecol. 2021;224(4):398.e1-398.e11.
Takase B, et al. Liposome-encapsulated hemoglobin (HbV) transfusion rescues rats present process progressive deadly 85% hemorrhage because of an anti-arrhythmogenic impact on the myocardium. Artif Organs. 2021;45(11):1391–404.
Sakai H. Overview of potential scientific functions of hemoglobin vesicles (HbV) as synthetic crimson cells, evidenced by preclinical research of the tutorial analysis consortium. J Funct Biomater. 2017. https://doi.org/10.3390/jfb8010010.
Fujihara M, et al. Major and secondary immune responses to keyhole limpet hemocyanin in rats after infusion of hemoglobin vesicle, a synthetic oxygen provider. Artif Organs. 2014;38(3):234–8.
Sakai H, et al. One-year commentary of Wistar rats after intravenous infusion of hemoglobin-vesicles (synthetic oxygen carriers). Artif Cells Blood Substit Immobil Biotechnol. 2007;35(1):81–91.
Sakai H, et al. Metabolism of hemoglobin-vesicles (synthetic oxygen carriers) and their affect on organ capabilities in a rat mannequin. Biomaterials. 2004;25(18):4317–25.
Sakai H, et al. Hemoglobin-vesicles as oxygen carriers: affect on phagocytic exercise and histopathological modifications in reticuloendothelial system. Am J Pathol. 2001;159(3):1079–88.
Taguchi Okay, et al. Hepatically-metabolized and -excreted synthetic oxygen provider, hemoglobin vesicles, might be safely used underneath circumstances of hepatic impairment. Toxicol Appl Pharmacol. 2010;248(3):234–41.
Taguchi Okay, et al. Organic responsiveness and metabolic efficiency of liposome-encapsulated hemoglobin (Hemoglobin-Vesicles) in apolipoprotein E-deficient mice after large intravenous injection. Biol Pharm Bull. 2015;38(10):1606–16.
Shono S, et al. Intraosseous transfusion with liposome-encapsulated hemoglobin improves mouse survival after hypohemoglobinemic shock with out scavenging nitric oxide. Shock. 2011;35(1):45–52.
Eriksson M, et al. The impact of hemorrhagic shock and intraosseous adrenaline injection on the supply of a subsequently administered drug – an experimental research. Scand J Trauma Resusc Emerg Med. 2019;27(1):29.
Yadav VR, et al. Nanovesicular liposome-encapsulated hemoglobin (LEH) prevents multi-organ accidents in a rat mannequin of hemorrhagic shock. Eur J Pharm Sci. 2016;93:97–106.
Nag OK, et al. Publish-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo. Int J Pharm. 2013;446(1–2):119–29.
Agashe H, et al. Improved formulation of liposome-encapsulated hemoglobin with an anionic non-phospholipid. Colloids Surf B Biointerfaces. 2010;75(2):573–83.
Mittal N, et al. Erythromer (EM), a Nanoscale Bio-Artificial Synthetic Purple Cell. In: Liu H, Kaye AD, Jahr JS, editors., et al., Blood substitutes and oxygen biotherapeutics. Cham: Springer Worldwide Publishing; 2022. p. 253–65.
Okamoto W, et al. Hemoglobin–albumin clusters as a synthetic O2 provider: Physicochemical properties and resuscitation from hemorrhagic shock in rats. J Biomed Mater Res B Appl Biomater. 2022;110(8):1827–38.
Liu Y, Ai Okay, Lu L. Polydopamine and its by-product supplies: synthesis and promising functions in vitality, environmental, and biomedical fields. Chem Rev. 2014;114(9):5057–115.
Zhao Y, et al. Hole PDA-Au nanoparticles-enabled sign amplification for delicate nonenzymatic colorimetric immunodetection of carbohydrate antigen 125. Biosens Bioelectron. 2015;71:200–6.
Baidukova O, et al. Antioxidative safety of haemoglobin microparticles (HbMPs) by PolyDopamine. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S693-s701.
Jansman MMT, et al. Hemoglobin-based oxygen carriers incorporating nanozymes for the depletion of reactive oxygen species. ACS Appl Mater Interfaces. 2020;12(45):50275–86.
Liu X, et al. Metallic-organic framework-based oxygen carriers with antioxidant exercise ensuing from the incorporation of gold nanozymes. Biomater Sci. 2023;11(7):2551–65.
Lian X, et al. Enzyme-MOF (metal-organic framework) composites. Chem Soc Rev. 2017;46(11):3386–401.
Chen Y, et al. Acid-resistant mesoporous metal-organic framework towards oral insulin supply: protein encapsulation, safety, and launch. J Am Chem Soc. 2018;140(17):5678–81.
Wang S, et al. DNA-functionalized metal-organic framework nanoparticles for intracellular supply of proteins. J Am Chem Soc. 2019;141(6):2215–9.
Liang Okay, et al. Biomimetic mineralization of metal-organic frameworks as protecting coatings for biomacromolecules. Nat Commun. 2015;6:7240.
Chen G, et al. A handy and versatile amino-acid-boosted biomimetic technique for the nondestructive encapsulation of biomacromolecules inside metal-organic frameworks. Angew Chem Int Ed Engl. 2019;58(5):1463–7.
Poddar A, et al. Encapsulation, visualization and expression of genes with biomimetically mineralized zeolitic imidazolate framework-8 (ZIF-8). Small. 2019;15(36):e1902268.
Jansman MMT, et al. Hemoglobin-based oxygen carriers camouflaged with membranes extracted from crimson blood cells: optimization and evaluation of performance. Biomater Adv. 2022;134:112691.
Solar H, et al. Actual-time model-based cerebral perfusion calculation for ischemic stroke. Comput Strategies Packages Biomed. 2024;243: 107916.
Demyanenko S, Dzreyan V, Sharifulina S. Histone deacetylases and their isoform-specific inhibitors in ischemic stroke. Biomedicines. 2021;9(10):1445.
Hurd MD, et al. Present standing of ischemic stroke remedy: from thrombolysis to potential regenerative medication. Regenerat Ther. 2021;18:408–17.
Wu DM, et al. Immune pathway activation in neurons triggers neural injury after stroke. Cell Rep. 2023;42(11):113368.
Jun-Lengthy H, et al. Necroptosis signaling pathways in stroke: from mechanisms to therapies. Curr Neuropharmacol. 2018;16(9):1327–39.
Lin W, Powers WJ. Oxygen metabolism in acute ischemic stroke. J Cereb Blood Stream Metab. 2018;38(9):1481–99.
Tirapelli CR. Oxidative stress and vascular illness. Curr Hypertens Rev. 2020;16(3):162.
Zuluaga Tamayo M, et al. Astaxanthin complexes to attenuate muscle injury after in vivo femoral ischemia-reperfusion. Mar Medication. 2019. https://doi.org/10.3390/md17060354.
Deuchar GA, et al. Preclinical validation of the therapeutic potential of glasgow oxygen stage dependent (GOLD) know-how: a theranostic for acute stroke. Transl Stroke Res. 2019;10(5):583–95.
Klaus JA, et al. Early remedy of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion. Synthetic Cell Blood Substitutes Biotechnol. 2010;38(5):223–9.
Kakehata J, et al. Therapeutic potentials of a synthetic oxygen-carrier, liposome-encapsulated hemoglobin, for ischemia/reperfusion-induced cerebral dysfunction in rats. J Pharmacol Sci. 2010;114(2):189–97.
Kaneda S, et al. Efficacy of liposome-encapsulated hemoglobin in a rat mannequin of cerebral ischemia. Artif Organs. 2014;38(8):650–5.
Cipolla MJ, et al. Pharmacologically rising collateral perfusion throughout acute stroke utilizing a carboxyhemoglobin fuel switch agent (Sanguinate™) in spontaneously hypertensive rats. J Cereb Blood Stream Metab. 2018;38(5):755–66.
Powanda DD, Chang TMS. Cross-linked polyhemoglobin-superoxide dismutase-catalase provides oxygen with out inflicting blood mind barrier disruption or mind edema in a rat mannequin of transient world mind ischemia-reperfusion. Synthetic Cell Blood Substitutes Biotechnol. 2002;30(1):23–37.
Xie Z, et al. The protecting impact of polymerized porcine hemoglobin (pPolyHb) on transient focal cerebral ischemia/reperfusion harm. Artif Cells Nanomed Biotechnol. 2015;43(3):180–5.
Caswell JE, et al. A novel hemoglobin-based blood substitute protects in opposition to myocardial reperfusion harm. Am J Physiol-Coronary heart Circulatory Physiol. 2005;288(4):H1796–801.
Komatsu H, et al. Impact of hemoglobin vesicle, a cellular-type synthetic oxygen provider, on center cerebral artery occlusion- and arachidonic acid-induced stroke fashions in rats. Neurosci Lett. 2007;421(2):121–5.
Fukumoto D, et al. Liposome-encapsulated hemoglobin reduces the scale of cerebral infarction in rats: impact of oxygen affinity. Artif Organs. 2009;33(2):159–63.
Kawaguchi AT, et al. Impact of oxygen affinity of liposome-encapsulated hemoglobin on cerebral ischemia and reperfusion as detected by positron emission tomography in nonhuman primates. Artif Organs. 2017;41(4):336–45.
Tomita D, et al. Covalent core-shell structure of hemoglobin and human serum albumin as a synthetic O2 provider. Biomacromol. 2013;14(6):1816–25.
Gekka M, et al. Novel hemoglobin-based oxygen provider certain with albumin reveals neuroprotection with doable antioxidant results. Stroke. 2018;49(8):1960–8.
Hosaka H, et al. Hemoglobin-albumin cluster incorporating a Pt nanoparticle: synthetic O2 provider with antioxidant actions. PLoS ONE. 2014;9(10):e110541.
Wang S, et al. Pan-immune-inflammatory worth predicts the three month consequence in acute ischemic stroke sufferers after intravenous thrombolysis. Curr Neurovasc Res. 2023. https://doi.org/10.2174/0115672026276427231024045957.
Haupt M, et al. Preconditioning ideas for the therapeutic use of extracellular vesicles in opposition to stroke. Stem Cells Transl Med. 2023. https://doi.org/10.1093/stcltm/szad055.
Yin N, et al. Engineered nanoerythrocytes alleviate central nervous system irritation by regulating the polarization of inflammatory microglia. Adv Mater. 2022;34(27):e2201322.
Shimbo D, et al. Publish-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin can cut back ischemia reperfusion harm. Mind Res. 2014;1554:59–66.
Shimbo D, et al. Superior microvascular perfusion of infused liposome-encapsulated hemoglobin previous to reductions in infarctions after transient focal cerebral ischemia. J Stroke Cerebrovasc Dis. 2017;26(12):2994–3003.
Choudhari OK, et al. Matrix metalloproteinase-9 gene polymorphism and its methylation in stroke sufferers. Malays J Med Sci. 2021;28(6):32–41.
Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: various therapeutic targets. Angiogenesis. 2017;20(4):409–26.
Liao C, et al. Tumor hypoxia: from primary data to therapeutic implications. Semin Most cancers Biol. 2023;88:172–86.
Dai Y, et al. Nanoparticle design methods for enhanced anticancer remedy by exploiting the tumour microenvironment. Chem Soc Rev. 2017;46(12):3830–52.
Kwon S, et al. Nanomedicines for reactive oxygen species mediated strategy: an rising paradigm for most cancers remedy. Acc Chem Res. 2019;52(7):1771–82.
Shi R, Tang YQ, Miao H. Metabolism in tumor microenvironment: Implications for most cancers immunotherapy. MedComm. 2020;1(1):47–68.
Semenza GL. Oxygen sensing, hypoxia-inducible elements, and illness pathophysiology. Annu Rev Pathol. 2014;9:47–71.
Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Most cancers. 2014;14(6):430–9.
Yang S, et al. Boosting the anti-tumor efficiency of disulfiram in opposition to glioblastoma by utilizing ultrasmall nanoparticles and HIF-1α inhibitor. Compos B Eng. 2022;243:110117.
Liu Y, et al. Modulation of hypoxia and redox within the stable tumor microenvironment with a catalytic nanoplatform to reinforce combinational chemodynamic/sonodynamic remedy. Biomater Sci. 2023;11(5):1739–53.
Huang J, et al. Oxygen-carrying nanoplatform to reprogram tumor immunosuppressive microenvironment and improve photothermal-immunotherapy. Mater As we speak Bio. 2023;19:100555.
Yuan CS, et al. Hypoxia-modulatory nanomaterials to alleviate tumor hypoxic microenvironment and improve immunotherapy: the place can we stand? Acta Biomater. 2021;125:1–28.
Telarovic I, Wenger RH, Pruschy M. Interfering with tumor hypoxia for radiotherapy optimization. J Exp Clin Most cancers Res. 2021;40(1):197.
Zhang J, et al. Nanotechnological methods to extend the oxygen content material of the tumor. Entrance Pharmacol. 2023;14:1140362.
Vaupel P, Multhoff G. Deadly alliance of hypoxia-/HIF-1α-Pushed microenvironmental traits selling most cancers development. Adv Exp Med Biol. 2020;1232:169–76.
Mortezaee Okay, Majidpoor J. The influence of hypoxia on immune state in most cancers. Life Sci. 2021;286:120057.
Doublier S, et al. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids through P-glycoprotein expression: a possible mannequin of the chemo-resistance of invasive micropapillary carcinoma of the breast. BMC Most cancers. 2012;12:4.
Samanta D, et al. Hypoxia-inducible elements are required for chemotherapy resistance of breast most cancers stem cells. Proc Natl Acad Sci U S A. 2014;111(50):E5429–38.
Kawaguchi F, et al. Liposome-encapsulated hemoglobin improves tumor oxygenation as detected by near-infrared spectroscopy in colon carcinoma in mice. Artif Organs. 2017;41(4):327–35.
Liu Y, et al. Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin. Sci Trans Med. 2016;8(348):348ra97-348ra97.
Zheng X, et al. Response to Touch upon “epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.” Sci Trans Med. 2017;9(391):eaam6298.
Chen L, et al. The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers underneath hypoxia in renal cell carcinoma. Theranostics. 2020;10(8):3562–78.
Guo Y, et al. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma remedy. ACS Appl Mater Interfaces. 2015;7(9):5444–53.
Synthesis of a hemoglobin-conjugated triblock copolymer for oxygen carrying and particular recognition of most cancers cells. RSC Adv., 2017; 7(76):48166–48175.
Yang, J., et al., Hypoxic tumor remedy by hemoglobin-mediated drug supply and reversal of hypoxia-induced chemoresistance. Biomaterials, 2018. 182: p. 145–156.
Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling brokers. Nat Rev Mol Cell Biol. 2020;21(7):363–83.
Jia S, et al. Selling reactive oxygen species technology: a key technique in nanosensitizer-mediated radiotherapy. Nanomedicine (Lond). 2021;16(9):759–78.
Huang L, et al. Photodynamic remedy for hypoxic tumors: advances and views. Coord Chem Rev. 2021;438:213888.
Li M, et al. Close to-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic remedy in opposition to hypoxic tumors. J Am Chem Soc. 2018;140(44):14851–9.
Wang S, et al. Hemoglobins from scapharca subcrenata (Bivalvia: Arcidae) possible play an bactericidal function by way of their peroxidase exercise. Comp Biochem Physiol B: Biochem Mol Biol. 2021;253:110545.
Wang R, et al. PEGylated hole gold nanoparticles for mixed X-ray radiation and photothermal remedy in vitro and enhanced CT imaging in vivo. Nanomed Nanotechnol Biol Med. 2019;16:195–205.
Goel S, Ni D, Cai W. Harnessing the ability of nanotechnology for enhanced radiation remedy. ACS Nano. 2017;11(6):5233–7.
Sang W, et al. Oxygen-enriched metal-phenolic X-ray nanoprocessor for most cancers radio-radiodynamic remedy together with checkpoint blockade immunotherapy. Adv Sci. 2021;8(4):2003338.
Hu CM, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526(7571):118–21.
Yu M, et al. Growth of “good” drug supply techniques for chemo/PDT synergistic remedy. J Mater Chem B. 2023;11(7):1416–33.
Mossakowska BJ, et al. Doable mechanisms of resistance improvement to photodynamic remedy (PDT) in vulvar most cancers cells. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms232314689.
Dang J, et al. Manipulating tumor hypoxia towards enhanced photodynamic remedy (PDT). Biomater Sci. 2017;5(8):1500–11.
Zhou Z, et al. Reactive oxygen species producing techniques assembly challenges of photodynamic most cancers remedy. Chem Soc Rev. 2016;45(23):6597–626.
Feng L, et al. Multifunctional UCNPs@MnSiO(3)@g-C(3)N(4) nanoplatform: improved ROS technology and decreased glutathione ranges for extremely environment friendly photodynamic remedy. Biomater Sci. 2017;5(12):2456–67.
Chae YC, et al. Mitochondrial akt regulation of hypoxic tumor reprogramming. Most cancers Cell. 2016;30(2):257–72.
Liang T, et al. Adapting and remolding: orchestrating tumor microenvironment normalization with photodynamic remedy by measurement transformable nanoframeworks. Angew Chem Int Ed Engl. 2021;60(20):11464–73.
Shi X, et al. Hemoglobin-mediated biomimetic synthesis of paramagnetic O(2)-evolving theranostic nanoprobes for MR imaging-guided enhanced photodynamic remedy of tumor. Theranostics. 2020;10(25):11607–21.
Wang S, et al. Synthesis of hemoglobin conjugated polymeric micelle: a ZnPc provider with oxygen self-compensating capability for photodynamic remedy. Biomacromol. 2015;16(9):2693–700.
Luo Z, et al. Self-monitoring synthetic crimson cells with ample oxygen provide for enhanced photodynamic remedy. Sci Rep. 2016;6:23393.
Cao H, et al. An assembled nanocomplex for enhancing each therapeutic effectivity and remedy depth in photodynamic remedy. Angew Chem Int Ed Engl. 2018;57(26):7759–63.
Chen Z, et al. Bioinspired hybrid protein oxygen nanocarrier amplified photodynamic remedy for eliciting anti-tumor immunity and abscopal impact. ACS Nano. 2018;12(8):8633–45.
Steeg PS. Tumor metastasis: mechanistic insights and scientific challenges. Nat Med. 2006;12(8):895–904.
Xu T, et al. Enhanced ferroptosis by oxygen-boosted phototherapy based mostly on a 2-in-1 nanoplatform of ferrous hemoglobin for tumor synergistic remedy. ACS Nano. 2020;14(3):3414–25.
Wang H, et al. Discovery of ML210-Primarily based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human most cancers cells. Eur J Med Chem. 2023;254:115343.
Hu H, et al. Rising nanomedicine-enabled/enhanced nanodynamic therapies past conventional photodynamics. Adv Mater. 2021;33(12):e2005062.
Jiang Q, et al. A hydrogen peroxide economizer for on-demand oxygen production-assisted sturdy sonodynamic immunotherapy. Theranostics. 2022;12(1):59–75.
Yin T, et al. Hypoxia-alleviated sonodynamic remedy based mostly on a hybrid protein oxygen provider to reinforce tumor inhibition. Biomater Sci. 2021;10(1):294–305.
Pan ZQ, et al. Building and analysis of zeolitic imidazolate framework-encapsulated hemoglobin microparticles as oxygen carriers. ACS Appl Bio Mater. 2023;6(4):1471–8.
Liang G, et al. Discount of platinum(IV) prodrug hemoglobin nanoparticles with deeply penetrating ultrasound radiation for tumor-targeted therapeutically enhanced anticancer remedy. Angew Chem Int Ed. 2023;62(22):e202301074.
Mortezaee Okay, Majidpoor J. The influence of hypoxia on extracellular vesicle secretome profile of most cancers. Med Oncol. 2023;40(5):128.
Wijekoon A, Fountas-Davis N, Leipzig ND. Fluorinated methacrylamide chitosan hydrogel techniques as adaptable oxygen carriers for wound therapeutic. Acta Biomater. 2013;9(3):5653–64.
Younis I. Function of oxygen in wound therapeutic. J Wound Care. 2020;29(Sup5b):S4-s10.
Gupta S, et al. Dynamic function of oxygen in wound therapeutic: a microbial, immunological, and biochemical perspective. Arch Razi Inst. 2022;77(2):513–23.
Sen CK. Wound therapeutic necessities: let there be oxygen. Wound Restore Regenerat. 2009;17(1):1–18.
Zhu Y, et al. Roxadustat promotes angiogenesis by way of HIF-1α/VEGF/VEGFR2 signaling and accelerates cutaneous wound therapeutic in diabetic rats. Wound Restore Regen. 2019;27(4):324–34.
Thangarajah H, et al. HIF-1α dysfunction in diabetes. Cell Cycle. 2010;9(1):75–9.
Fosen KM, Thom SR. Hyperbaric oxygen, vasculogenic stem cells, and wound therapeutic. Antioxid Redox Sign. 2014;21(11):1634–47.
Wang X, et al. In situ 3D bioprinting dwelling photosynthetic scaffolds for autotrophic wound therapeutic. Analysis. 2022. https://doi.org/10.34133/2022/9794745.
Kang JI, Park KM. Oxygen-supplying syringe to create hyperoxia-inducible hydrogels for in situ tissue regeneration. Biomaterials. 2023;293:121943.
Zhao E, et al. Separable microneedles with photosynthesis-driven oxygen manufactory for diabetic wound therapeutic. ACS Appl Mater Interfaces. 2023;15(6):7725–34.
Chen H, et al. Dissolved oxygen from microalgae-gel patch promotes continual wound therapeutic in diabetes. Sci Adv. 2020;6(20):eaba4311.
Wang T, et al. Mixed antioxidant-antibiotic remedy for successfully therapeutic contaminated diabetic wounds based mostly on polymer vesicles. ACS Nano. 2021;15(5):9027–38.
Hauck S, et al. Collagen/hyaluronan based mostly hydrogels releasing sulfated hyaluronan enhance dermal wound therapeutic in diabetic mice through lowering inflammatory macrophage exercise. Bioact Mater. 2021;6(12):4342–59.
Wang S, et al. Nanoenzyme-reinforced injectable hydrogel for therapeutic diabetic wounds contaminated with multidrug resistant micro organism. Nano Lett. 2020;20(7):5149–58.
Jia Z, et al. Bioinspired conductive silk microfiber built-in bioelectronic for analysis and wound therapeutic in diabetes. Adv Func Mater. 2021;31(19):2010461.
Chen Y, et al. Analysis advances in good responsive-hydrogel dressings with potential scientific diabetic wound therapeutic properties. Mil Med Res. 2023;10(1):37.
Thangarajah H, et al. The molecular foundation for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A. 2009;106(32):13505–10.
Fukui T, et al. Liposome-encapsulated hemoglobin accelerates pores and skin wound therapeutic in diabetic dB/dB mice. Artif Organs. 2017;41(4):319–26.
Rius J, et al. NF-kappaB hyperlinks innate immunity to the hypoxic response by way of transcriptional regulation of HIF-1alpha. Nature. 2008;453(7196):807–11.
Jin L, et al. An NIR photothermal-responsive hybrid hydrogel for enhanced wound therapeutic. Bioact Mater. 2022;16:162–72.
Peng Y, et al. Building of heparin-based hydrogel integrated with Cu5.4O ultrasmall nanozymes for wound therapeutic and irritation inhibition. Bioact Mater. 2021;6(10):3109–24.
Waris TS, et al. Chitosan-sodium percarbonate-based hydrogels with sustained oxygen launch potential stimulated angiogenesis and accelerated wound therapeutic. J Biomed Mater Res B Appl Biomater. 2023. https://doi.org/10.1002/jbm.b.35344.
Yang Z, et al. Oxygen-generating hydrogels as oxygenation remedy for accelerated continual wound therapeutic. Adv Healthc Mater. 2023. https://doi.org/10.1002/adhm.202302391.
Shiekh PA, Singh A, Kumar A. Oxygen-releasing antioxidant cryogel scaffolds with sustained oxygen supply for tissue engineering functions. ACS Appl Mater Interfaces. 2018;10(22):18458–69.
Frykberg R, et al. Use of Topical Oxygen Remedy in Wound Therapeutic. J Wound Care. 2023;32(Sup8b):S1-s32.
Liu Y, et al. Responsive porous microcarriers with controllable oxygen supply for wound therapeutic. Small. 2019;15(21):e1901254.
Zhang X, et al. Encoded microneedle arrays for detection of pores and skin interstitial fluid biomarkers. Adv Mater. 2019;31(37):e1902825.
Li W, et al. Quickly separable microneedle patch for the sustained launch of a contraceptive. Nat Biomed Eng. 2019;3(3):220–9.
Priya S, et al. Concurrent incidence of lobular capillary haemangioma and port-wine stain: a case report and literature assessment. Cureus. 2023;15(5):e38642.
Demirel Öğüt N. Acquired plantar port-wine stain (Fegeler syndrome) following extended standing. J Cosmet Dermatol. 2022;21(10):5234–5.
Jiang F, et al. Affect of port-wine stains on high quality of life of youngsters and their dad and mom. Acta Derm Venereol. 2021;101(8):adv00516.
Artzi O, et al. Therapy of port wine stain with Tixel-induced rapamycin supply following pulsed dye laser utility. Dermatol Ther. 2020;33(1):e13172.
Sabeti S, et al. Consensus assertion for the administration and remedy of port-wine birthmarks in sturge-weber syndrome. JAMA Dermatol. 2021;157(1):98–104.
Yang C, et al. Mapping port wine stain in vivo by optical coherence tomography angiography and multi-metric characterization. Choose Categorical. 2023;31(9):13613–26.
Sakai H, et al. O2 launch from Hb vesicles evaluated utilizing a synthetic, slender O2-permeable tube: comparability with RBCs and acellular Hbs. Am J Physiol-Coronary heart Circulatory Physiol. 2003;285(6):H2543–51.
Rikihisa N, et al. Synthetic crimson blood cells as potential photosensitizers in dye laser remedy in opposition to port-wine stains. J Funct Biomater. 2017;8(2):14.
Ranjbar A, et al. Machine studying fashions for predicting pre-eclampsia: a scientific assessment protocol. BMJ Open. 2023;13(9):e074705.
Davidson KW, et al. Screening for gestational diabetes: us preventive providers job drive advice assertion. JAMA. 2021;326(6):531–8.
Henderson JT, et al. Preeclampsia screening: proof report and systematic assessment for the US preventive providers job drive. JAMA. 2017;317(16):1668–83.
Burton GJ, et al. Rheological and physiological penalties of conversion of the maternal spiral arteries for uteroplacental blood stream throughout human being pregnant. Placenta. 2009;30(6):473–82.
Fruci S, et al. Pravastatin for extreme preeclampsia with development restriction: Placental findings and toddler follow-up. Eur J Obstet Gynecol Reprod Biol. 2023;283:37–42.
Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost. 2009;7(3):375–84.
Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a illness of the maternal endothelium: the function of antiangiogenic elements and implications for later heart problems. Circulation. 2011;123(24):2856–69.
Cotechini T, et al. Irritation in rat being pregnant inhibits spiral artery reworking resulting in fetal development restriction and options of preeclampsia. J Exp Med. 2014;211(1):165–79.
Kawaguchi AT, et al. Liposome-encapsulated hemoglobin reduces the scale of cerebral infarction within the rat. Stroke. 2007;38(5):1626–32.
Chang TMS. Therapeutic functions of polymeric synthetic cells. Nat Rev Drug Discovery. 2005;4(3):221–35.
Ohta H, et al. Potential new non-invasive remedy utilizing synthetic oxygen carriers for pre-eclampsia. J Funct Biomater. 2017. https://doi.org/10.3390/jfb8030032.
Mysak J, et al. Porphyromonas gingivalis: main periodontopathic pathogen overview. J Immunol Res. 2014;2014:476068.
Yang J, et al. Porphyromonas gingivalis oral an infection promote T helper 17/Treg imbalance within the improvement of atherosclerosis. J Dent Sci. 2017;12(1):60–9.
Paramaesvaran M, et al. Porphyrin-Mediated Cell Floor Heme Seize from Hemoglobin by <i>Porphyromonas gingivalis</i>. J Bacteriol. 2003;185(8):2528–37.
Bai L, et al. Oxyhemoglobin-based nanophotosensitizer for particular and synergistic photothermal and photodynamic therapies in opposition to porphyromonas gingivalis oral an infection. ACS Biomater Sci Eng. 2023;9(1):485–97.
Mao C, et al. Native photothermal/photodynamic synergistic remedy by disrupting bacterial membrane to speed up reactive oxygen species permeation and protein leakage. ACS Appl Mater Interfaces. 2019;11(19):17902–14.
Zhang H, et al. Twin-mode antibacterial conjugated polymer nanoparticles for photothermal and photodynamic remedy. Macromol Biosci. 2020;20(2):e1900301.
Hu X, et al. Synergistic antibacterial technique based mostly on photodynamic remedy: Progress and views. Chem Eng J. 2022;450:138129.
Paciello A, et al. Hemoglobin-conjugated gelatin microsphere as a wise oxygen releasing biomaterial. Adv Healthc Mater. 2016;5(20):2655–66.
Jones GL, et al. Time course and quantification of pancreatic islet revasculariztion following intraportal transplantation. Cell Transplant. 2007;16(5):505–16.
Rodriguez-Brotons A, et al. Impression of pancreatic rat islet density on cell survival throughout hypoxia. J Diabetes Res. 2016;2016:3615286.
Okere B, et al. Cell therapies for pancreatic beta-cell replenishment. Ital J Pediatr. 2016;42(1):62.
Mouré A, et al. Extracellular hemoglobin mixed with an O(2) -generating materials overcomes O(2) limitation within the bioartificial pancreas. Biotechnol Bioeng. 2019;116(5):1176–89.
Le Pape F, et al. Development in recombinant protein manufacturing utilizing a marine oxygen provider to reinforce oxygen switch in a CHO-S cell line. Artif Cells Nanomed Biotechnol. 2015;43(3):186–95.
Sue C-Y, Tsai N-C. Human powered MEMS-based vitality harvest gadgets. Appl Vitality. 2012;93:390–403.
Zebda A, et al. Mediatorless high-power glucose biofuel cells based mostly on compressed carbon nanotube-enzyme electrodes. Nat Commun. 2011;2:370.
Weltin A, et al. Polymer-based, versatile glutamate and lactate microsensors for in vivo functions. Biosens Bioelectron. 2014;61:192–9.
Chen H, et al. In Situ Engineering of Intracellular Hemoglobin for Implantable Excessive-Efficiency Biofuel Cells. Angew Chem Int Ed Engl. 2019;58(20):6663–8.
Rikihisa N, et al. Synthetic crimson blood cells as potential photosensitizers in dye laser remedy in opposition to port-wine stains. J Funct Biomater. 2017. https://doi.org/10.3390/jfb8020014.